Pravastatin reduced major coronary heart disease (CHD) events in patients with abnormal fasting glucose and a history of CHD
- PMID: 15230553
Pravastatin reduced major coronary heart disease (CHD) events in patients with abnormal fasting glucose and a history of CHD
Comment on
-
Secondary prevention of cardiovascular events with long-term pravastatin in patients with diabetes or impaired fasting glucose: results from the LIPID trial.Diabetes Care. 2003 Oct;26(10):2713-21. doi: 10.2337/diacare.26.10.2713. Diabetes Care. 2003. PMID: 14514569 Clinical Trial.